Azenta, Inc. (AZTA)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Azenta, Inc. keeps $2 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 20
in 71 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Azenta topped consensus on both the top and bottom line in the third fiscal quarter of 2026, reported August 4, 2026, with adjusted EPS of $0.16 topping the $0.11 estimate (+41%) even as it fell -15.8% from $0.19 a year ago. Revenue rose 12.0% to roughly $161.2 million (up from about $143.9 million a year ago) and also topped expectations, coming in at $161.2 million versus a $149.3 million estimate (+8%). Profitability was mixed: gross profit was about $72.4 million, translating to a gross margin of roughly 45%, while operating results were negative with operating income of roughly -$4.2 million and an operating margin of about -3%. The company generated about $2.8 million of operating cash flow during the quarter and repurchased roughly $50.0 million of stock. For the next period, consensus calls for EPS of $0.16 on revenue of $160.3 million.
About Azenta, Inc.
Azenta, Inc. provides tools and services for handling life science samples, operating in healthcare through laboratory instruments, supplies, and related services. On NASDAQ under AZTA, the company specializes in the discovery, handling, and preservation of those samples and recorded $593.8 million of revenue in FY2025.
Today's Snapshot
AZTA closed 2.2% lower at 30.15.
Trading Volume
Above 10d avg 802.5K
839.6K
vs S&P 500 Today
Underperforming Market
-1.69%
Updated: September 10, 2026 at 12:10 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$28.30 - $31.98Buy
- RSI (14)41.97Neutral
- Stochastic %K (14, 3, 3)5.31Buy
- MACD Level (12, 26)0.16Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.